Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in SHC — Sotera Health Co

CIK 1115418 BOSTON, MA
Back to SHC Full portfolio

Position in SHC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$11,719,224
+$3,711,281 QoQ
Shares Held
660,238
+18.2% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 319 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 48% Shared 0% None 52%

Common Shares in SHC Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,233,577,400 across 30 Diagnostics & Research names. SHC ranks #16 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 593,946 $297,780,766
2 DHR
Danaher Corp /De/
 995,923 $189,703,413
3 ILMN
Illumina, Inc.
 560,716 $98,590,694
4 IDXX
Idexx Laboratories Inc /De
 169,208 $89,077,859
5 A
Agilent Technologies, Inc.
 500,807 $66,522,193
6 IQV
Iqvia Holdings Inc.
 332,138 $64,175,704
7 WAT
Waters Corp /De/
 168,771 $63,295,875
8 DGX
Quest Diagnostics Inc
 267,727 $56,744,737

All Filings in SHC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,719,224 660,238
2026-03-31 $8,007,943 558,434
2025-12-31 $8,878,423 503,312
2025-09-30 $6,994,187 444,640
2025-06-30 $4,478,568 402,749
2025-03-31 $4,603,251 394,790
2024-12-31 $5,460,659 399,171
2024-09-30 $6,422,068 384,555
2024-06-30 $3,742,053 315,253
2024-03-31 $4,017,645 334,525
2023-12-31 $4,854,822 288,120
2023-09-30 $4,646,047 310,150
2023-06-30 $5,871,843 311,669
2023-03-31 $5,504,065 307,318
2022-12-31 $2,452,993 294,477
2022-09-30 $1,925,333 282,307
2022-06-30 $5,425,959 276,976
2022-03-31 $1,857,561 85,760
2021-12-31 $2,105,252 89,395
2021-09-30 $2,167,050 82,870
2021-06-30 $1,652,922 68,218
2021-03-31 $1,264,323 50,654